Persephone Biosciences is pioneering the use of synthetic biology for the development of microbial products that impact patient and infant health. Persephone is building an end-to-end platform to industrialize the development of engineered cells that restore health to damaged human ecosystems.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 07/19/22 | $15,000,000 | Seed |
BrightEdge Fund Fifty Years First Bight Ventures  Pioneer Fund Propel Bio Partners Susa Ventures Y Combinator Zhen Fund | undisclosed |
